BACKGROUND: Ovarian sex-cord stromal tumors (SCST) take up 5% of the ovarian neoplasm and may develop in?to?an ovarian mass or a haemoperitoneum. The surgical management of SCST in early-stage adult patients is not we...BACKGROUND: Ovarian sex-cord stromal tumors (SCST) take up 5% of the ovarian neoplasm and may develop in?to?an ovarian mass or a haemoperitoneum. The surgical management of SCST in early-stage adult patients is not well?defined. CASE REPORT: A 69 year-old postmenopausal woman was admitted for metrorrhagia, a right ovary mass and?increasing pelvic pain. Preoperative clinical and instrumental examination suspected an ovarian tumor, and the?laparoscopic right ophorectomy and the frozen section suggested an ovarian SCST. To fast restore and preserve woman?integrity, total laparoscopic hysterectomy (TLH) plus left salpingo-ophorectomy (SO) were performed, without complications?in the short and long term follow-up. CONCLUSION: In the authors’ opinion, the minimally invasive management?of SCST by TLH plus bilateral SO followed by a prolonged surveillance and without intensive surgical staging,?could be an appropriate clinical and surgical choice in elder patient at early stage, since these tumors are slow at?growth, recurring locally and only a long time after initial treatment. We suggest, after a minimally invasive treatment,?a possible “wait and see” option, as in our case report.展开更多
Background: Ovarian sex cord-stromal tumors are an uncommon heterogeneous group of tumors with different biological behaviors and clinico-patho- logic aspects. Aim of the Work: This study will review the clinico-patho...Background: Ovarian sex cord-stromal tumors are an uncommon heterogeneous group of tumors with different biological behaviors and clinico-patho- logic aspects. Aim of the Work: This study will review the clinico-pathologic aspects of sex-cord stromal ovarian tumors at the National Cancer Institute (NCI), Cairo University, Egypt, as well as their management and follow-up regarding disease free survival and overall survival. Patients and Methods: This retrospective study was conducted at the National Cancer Institute Cairo University, Egypt on female patients with ovarian sex cord stromal tumors in the period from January 2008 to December 2012 with a follow-up period of 24 to 84 months. The age of the patients, different clinical presentations, radiological findings, associated uterine bleeding (need for endometrial biopsy), pre-operative CA125 levels, surgical management done, different histopathological types, different biological behaviors, presence of ascites (and its correlation with the histopathology), Adjuvant chemotherapy (according to biological behavior and pathological type), and follow-up of non-benign cases for up to 84 months will all be documented and studied. Results: The mean age at presentation was 47.34;abdominal pain and mass were the commonest presentations 54.5% and 53.2% respectively;the main radiologic findings were a pelvic mass +/- ascites which had no correlation to the pathological type (p = 0.075). Endometrial hyperplasia and endometrial carcinoma were associated with 22% and 2.5% of cases respectively. Stages I and II represented 95% of patients with non-benign tumors (48 patients). Panhysterectomy +/- infracolic omentectomy or fertility sparing surgery were done in 70.1% and 29.9% of patients respectively. AGCTs were the commonest pathological type (49.4%). Adjuvant chemotherapy was given to 14 patients (46.7%) with non-benign tumors. 6 recurrences (20%) in 30 patients with non-benign tumors on regular follow-up were documented. The median of disease free survival (DFS) was 50.5 months. The median overall survival was 49.5 months. Conclusion: Ovarian SCSTs are uncommon neoplasms with different biological behaviors where AGCTs are the commonest among Egyptian females. Hormonal manifestations are uncommon where abnormal vaginal bleeding is the commonest one. The presence of ascitic fluid has no correlation with the pathological type of the tumor. Early stages (I and II) represented about 95% of non-benign tumors. Surgical management without lymphadenectomy +/- adjuvant chemotherapy is the main line of treatment at our institute. The OS was shorter than that documented in the literature. A small number of patients, reluctance of follow-up and unavailability of some patients’ data were the main drawbacks in this study.展开更多
目的探讨衰老的卵巢间质成纤维细胞对卵巢癌细胞系SKOV3的增殖、侵袭能力的影响。方法原代培养人卵巢正常成纤维细胞(NOF),在体外持续传代诱导细胞衰老,用衰老相关的β半乳糖苷酶染色(SA-b-gal)试验检测细胞是否发生衰老。收集正常成纤...目的探讨衰老的卵巢间质成纤维细胞对卵巢癌细胞系SKOV3的增殖、侵袭能力的影响。方法原代培养人卵巢正常成纤维细胞(NOF),在体外持续传代诱导细胞衰老,用衰老相关的β半乳糖苷酶染色(SA-b-gal)试验检测细胞是否发生衰老。收集正常成纤维细胞的条件培养基(CMn)及衰老成纤维细胞的条件培养基(CMs)。用CMn和CMs分别处理SKOV3细胞,利用CCK8试剂盒、Tra ns we ll小室及三维培养试验检测细胞的增殖、侵袭能力的变化。结果卵巢正常成纤维细胞在体外持续传代会导致细胞复制性衰老,在SA-b-gal试验中有明显的深蓝色沉淀产物。用CMs处理SKOV3细胞,CCK8试验显示细胞培养第5天的OD(2.067±0.058)高于CMn组(1.073±0.056)(t=21.19,P<0.01),表明细胞的增殖能力增强。Tra ns we ll试验显示CMs组穿透Ma trig e l胶的细胞数(235.00±29.68)个,较CMn组的(129.30±15.52)个明显增多(t=5.47,P<0.01);三维培养中形成的克隆球CMs组较CMn组明显增大、数量明显增多(27.00±2.16 vs 11.67±2.50;t=8.04,P<0.01),向外侵袭能力增强。结论衰老的卵巢间质成纤维细胞在体外培养中能促进卵巢癌细胞的增殖和侵袭能力。展开更多
文摘BACKGROUND: Ovarian sex-cord stromal tumors (SCST) take up 5% of the ovarian neoplasm and may develop in?to?an ovarian mass or a haemoperitoneum. The surgical management of SCST in early-stage adult patients is not well?defined. CASE REPORT: A 69 year-old postmenopausal woman was admitted for metrorrhagia, a right ovary mass and?increasing pelvic pain. Preoperative clinical and instrumental examination suspected an ovarian tumor, and the?laparoscopic right ophorectomy and the frozen section suggested an ovarian SCST. To fast restore and preserve woman?integrity, total laparoscopic hysterectomy (TLH) plus left salpingo-ophorectomy (SO) were performed, without complications?in the short and long term follow-up. CONCLUSION: In the authors’ opinion, the minimally invasive management?of SCST by TLH plus bilateral SO followed by a prolonged surveillance and without intensive surgical staging,?could be an appropriate clinical and surgical choice in elder patient at early stage, since these tumors are slow at?growth, recurring locally and only a long time after initial treatment. We suggest, after a minimally invasive treatment,?a possible “wait and see” option, as in our case report.
文摘Background: Ovarian sex cord-stromal tumors are an uncommon heterogeneous group of tumors with different biological behaviors and clinico-patho- logic aspects. Aim of the Work: This study will review the clinico-pathologic aspects of sex-cord stromal ovarian tumors at the National Cancer Institute (NCI), Cairo University, Egypt, as well as their management and follow-up regarding disease free survival and overall survival. Patients and Methods: This retrospective study was conducted at the National Cancer Institute Cairo University, Egypt on female patients with ovarian sex cord stromal tumors in the period from January 2008 to December 2012 with a follow-up period of 24 to 84 months. The age of the patients, different clinical presentations, radiological findings, associated uterine bleeding (need for endometrial biopsy), pre-operative CA125 levels, surgical management done, different histopathological types, different biological behaviors, presence of ascites (and its correlation with the histopathology), Adjuvant chemotherapy (according to biological behavior and pathological type), and follow-up of non-benign cases for up to 84 months will all be documented and studied. Results: The mean age at presentation was 47.34;abdominal pain and mass were the commonest presentations 54.5% and 53.2% respectively;the main radiologic findings were a pelvic mass +/- ascites which had no correlation to the pathological type (p = 0.075). Endometrial hyperplasia and endometrial carcinoma were associated with 22% and 2.5% of cases respectively. Stages I and II represented 95% of patients with non-benign tumors (48 patients). Panhysterectomy +/- infracolic omentectomy or fertility sparing surgery were done in 70.1% and 29.9% of patients respectively. AGCTs were the commonest pathological type (49.4%). Adjuvant chemotherapy was given to 14 patients (46.7%) with non-benign tumors. 6 recurrences (20%) in 30 patients with non-benign tumors on regular follow-up were documented. The median of disease free survival (DFS) was 50.5 months. The median overall survival was 49.5 months. Conclusion: Ovarian SCSTs are uncommon neoplasms with different biological behaviors where AGCTs are the commonest among Egyptian females. Hormonal manifestations are uncommon where abnormal vaginal bleeding is the commonest one. The presence of ascitic fluid has no correlation with the pathological type of the tumor. Early stages (I and II) represented about 95% of non-benign tumors. Surgical management without lymphadenectomy +/- adjuvant chemotherapy is the main line of treatment at our institute. The OS was shorter than that documented in the literature. A small number of patients, reluctance of follow-up and unavailability of some patients’ data were the main drawbacks in this study.
文摘目的探讨衰老的卵巢间质成纤维细胞对卵巢癌细胞系SKOV3的增殖、侵袭能力的影响。方法原代培养人卵巢正常成纤维细胞(NOF),在体外持续传代诱导细胞衰老,用衰老相关的β半乳糖苷酶染色(SA-b-gal)试验检测细胞是否发生衰老。收集正常成纤维细胞的条件培养基(CMn)及衰老成纤维细胞的条件培养基(CMs)。用CMn和CMs分别处理SKOV3细胞,利用CCK8试剂盒、Tra ns we ll小室及三维培养试验检测细胞的增殖、侵袭能力的变化。结果卵巢正常成纤维细胞在体外持续传代会导致细胞复制性衰老,在SA-b-gal试验中有明显的深蓝色沉淀产物。用CMs处理SKOV3细胞,CCK8试验显示细胞培养第5天的OD(2.067±0.058)高于CMn组(1.073±0.056)(t=21.19,P<0.01),表明细胞的增殖能力增强。Tra ns we ll试验显示CMs组穿透Ma trig e l胶的细胞数(235.00±29.68)个,较CMn组的(129.30±15.52)个明显增多(t=5.47,P<0.01);三维培养中形成的克隆球CMs组较CMn组明显增大、数量明显增多(27.00±2.16 vs 11.67±2.50;t=8.04,P<0.01),向外侵袭能力增强。结论衰老的卵巢间质成纤维细胞在体外培养中能促进卵巢癌细胞的增殖和侵袭能力。
